Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
作者:
主题词
血管生成抑制剂(Angiogenesis Inhibitors);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);苯磺酸盐类(Benzenesulfonates);乳腺肿瘤(Breast Neoplasms);心脏毒素类(Cardiotoxins);心血管疾病(Cardiovascular Diseases);女(雌)性(Female);心力衰竭(Heart Failure);人类(Humans);吲哚类(Indoles);分子靶向治疗(Molecular Targeted Therapy);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);蛋白激酶抑制剂(Protein Kinase Inhibitors);吡啶类(Pyridines);吡咯类(Pyrroles);喹唑啉类(Quinazolines);危险性评估(Risk Assessment)
DOI
10.1016/j.breast.2010.11.002
PMID
21146409
发布时间
2022-04-08
- 浏览20
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文